Telix Pharmaceuticals (TLPPF) Current Taxes (2023 - 2026)

Telix Pharmaceuticals (TLPPF) has reported Current Taxes for 4 consecutive years, with $33.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Taxes changed N/A year-over-year to $33.9 million in Q2 2026; TTM through Jun 2026 was $33.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $30.7 million, down 42.19% from the prior year.
• Current Taxes was $33.9 million for Q2 2026 at Telix Pharmaceuticals, up from $30.7 million in the prior quarter.
• Over five years, Current Taxes peaked at $33.9 million in Q2 2026 and troughed at $12.5 million in Q4 2023.
• A 4-year average of $27.2 million and a median of $31.3 million in 2024 frame the typical range for Current Taxes.
• Across the five-year window, Current Taxes jumped 154.64% in 2024 and fell 3.23% in 2025, its largest moves.
• Over 4 years, Current Taxes stood at $12.5 million in 2023, then jumped by 154.64% to $31.8 million in 2024, then retreated by 3.23% to $30.7 million in 2025, then rose by 10.12% to $33.9 million in 2026.
• The last three Current Taxes figures came in at $33.9 million (Q2 2026), $30.7 million (Q4 2025), and $31.8 million (Q4 2024), per Business Quant data.